Glucomed

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Glucomed

Quick Facts

Property Description
Active Ingredient Glucosamine sulfate
Form Oral preparations (tablets, capsules, powder)
Pharmacological Class Non-steroidal anti-inflammatory and anti-rheumatic (SYSADOA)
General Purpose Supports cartilage structure and joint function
Origin Typically derived from natural sources (shellfish)

What Type of Medicine is Glucomed? (Identity and Classification)

Glucomed is a medicinal preparation whose active component is Glucosamine sulfate, a single-active-ingredient product classified within the group of Non-steroidal anti-inflammatory and anti-rheumatic products. This pharmacological classification identifies it as a Symptomatic Slow-Acting Drug for Osteoarthritis (SYSADOA).

This distinction is clinically significant because its therapeutic focus is on the long-term support of joint tissue, unlike fast-acting analgesics. The preparation is intended for systemic administration and is available in various oral preparations, including tablets, capsules, or powder for oral solution, offering flexibility for adult patients. Glucosamine is used in the symptomatic treatment of mild to moderate knee osteoarthritis.

Composition and Origin: Is Glucosamine a Natural Substance?

The main substance in Glucomed is Glucosamine, an aminosaccharide that functions as an endogenous substance naturally vital to joint health. The compound, utilized as the sulfate salt in this medicine, serves as a fundamental cartilage building block and necessary precursor for the synthesis of proteoglycans.

While Glucosamine is natural to the body, the medicinal supply is often derived from natural sources such as the shells of shellfish. This targeted composition delivers the structural material required to support the creation and maintenance of the cartilage matrix. Pharmacologically, the compound serves as a precursor for these essential joint components. This function supports the maintenance of joint cushioning support over time.

What is the General Purpose of Glucomed? (Core Therapeutic Intent)

The general purpose of Glucomed is to act as a cartilage metabolism regulator that provides a recognized chondroprotective effect within the joints. It supports the stability and structural integrity of the joint's supportive tissue by intervening in the biochemical processes necessary for cartilage health.

This core activity is intended to support the long-term function and stability of the joints. The overall therapeutic intent is to support the joint structure, which is the foundational goal for this class of medicine.

What side effects are possible with Glucomed?

Possible Side Effects and Safety Information

This information describes the documented safety profile and adverse reactions for Glucomed (Glucosamine hydrochloride) as published in official government regulatory documents (e.g., EMA/SmPC).

Adverse Reactions Classified by Frequency

Side effects are categorized by how often they may occur:

Frequency Examples of Adverse Reactions (Not Exhaustive)
Common (1 in 100 to 1 in 10 users) Nausea, abdominal pain, indigestion, diarrhea, constipation, headache, tiredness.
Uncommon (1 in 1,000 to 1 in 100 users) Skin rash, itching (pruritus), flushing.
Not Known (Cannot be estimated) Allergic reactions, hepatic enzyme elevation, blood glucose changes, blood pressure changes, worsening of asthma, INR fluctuation.

Serious Adverse Reactions and Safety Constraints

  • Hypersensitivity: Severe allergic reactions (including swelling of the face/throat) are possible. The medicine is contraindicated in patients with known shellfish allergy as the ingredient is often derived from shellfish.
  • Blood Clotting: INR (International Normalised Ratio) fluctuation has been reported in patients taking coumarin anticoagulants (e.g., warfarin), which requires careful monitoring.
  • Blood Glucose: Monitoring of blood glucose levels is recommended for patients with pre-existing impaired glucose tolerance or diabetes mellitus.
  • Contraindications: The medicine is not recommended for use in pregnant or breastfeeding women due to inadequate safety data.
  • Paediatric Use: Contraindicated in children and adolescents under 18 years of age due to lack of established safety and efficacy.

Overdose and Emergency Response

Overdose and When to Seek Help

The regulatory profile for Glucomed (Metformin) overdose is structured around the primary risk of Lactic Acidosis, a rare but serious metabolic complication that can be fatal. Documented clinical presentations preceding this event include non-specific signs such as severe malaise (general discomfort), myalgia (muscle pain), somnolence (drowsiness), and respiratory distress, often accompanied by severe gastrointestinal distress.

Regulatory Mandates and Management

Immediate emergency medical care is mandated if overdose is suspected or if any symptoms suggesting Lactic Acidosis are present. The medication must be discontinued immediately upon the first sign of these symptoms. Official labeling notes that impaired renal function and advanced age (e.g., over 65) significantly increase the risk of drug accumulation and overdose severity. For management, no specific antidote is known. However, hemodialysis is the explicitly mandated management procedure, as it is the most effective method for removing both the accumulated drug and lactate from the blood. Close clinical and laboratory monitoring of acid-base balance and renal function is required in a hospital setting.

Therapeutic Uses of Glucomed

Quick Facts: Uses of Glucomed

  • Supports the management of joint symptoms related to osteoarthritis.
  • Assists in improving functional ability in adults with mild to moderate knee osteoarthritis.
  • Is an adjunct to lifestyle modifications and physical therapy.
  • May be used for long-term supportive care of joint tissues.

Glucomed (active ingredient Glucosamine sulfate) is a medication used to improve the symptomatic management of osteoarthritis in conjunction with lifestyle modifications. It is intended to help achieve relief from symptoms and support joint mobility in adult patients.

The medication supports the body's processes by providing structural components for cartilage, and may contribute to the maintenance of the joint matrix. This helps in maintaining joint function over time, which is a core part of managing the condition.

It is commonly used as a therapeutic option in the medical management of osteoarthritis. The uses for the medication are established to ensure appropriate therapeutic application for joint health.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Glucomed (Metformin) — Official Regulatory Information

The following rules define population eligibility for Glucomed (Metformin) as established by authoritative government regulatory agencies (e.g., FDA, EMA). These constraints determine who is allowed to use the medicine and who is absolutely prohibited from use.

Eligibility Scope Details from Regulatory Labels
Populations Allowed Adults and pediatric patients 10 years of age and older with Type 2 Diabetes.
Absolute Contraindications Severe renal impairment (eGFR below 30 mL/ min/1.73 m^2), metabolic acidosis (including diabetic ketoacidosis), and known hypersensitivity to the medicine.
Condition-Specific Restrictions Hepatic impairment (use is generally avoided); acute/unstable congestive heart failure; conditions causing tissue hypoxemia; and excessive alcohol intake.
Conditional Use & Monitoring Patients with eGFR 30- 44 mL/ min/1.73 m^2 (initiating treatment is not recommended). Older adults (ge 65 years) require more frequent monitoring of renal function.
Temporary Discontinuation Required before surgical procedures and diagnostic imaging involving iodinated contrast media; can be restarted only after renal function is stable.
Pregnancy/Lactation Status Metformin is generally compatible with breastfeeding; the decision for use during pregnancy is made based on individual need and maintaining glycemic control.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Limited clinical data are available regarding the interaction potential of Glucomed (glucosamine) with other medicinal products. Formal drug interaction studies have not been performed for glucosamine-containing products, warranting a general caution when used concurrently with any other medicine.

Anticoagulants

Of particular concern is a potential interaction with coumarin anticoagulants, such as Warfarin. Post-marketing surveillance reports have indicated a possible interaction leading to an increase in the International Normalized Ratio (INR) parameter, which suggests an augmented anticoagulant effect and an elevated risk of bleeding. The mechanism for this potential interaction is currently not established.

Patients taking oral vitamin K antagonists (coumarin anticoagulants) should be subject to close monitoring of their INR values when initiating or discontinuing Glucomed therapy.

Tetracyclines

Concurrent use may potentially increase the absorption and serum concentration of tetracyclines; however, the clinical significance of this specific interaction is likely limited.

Mechanism of Action

How Glucomed Works

The physiological action of Glucosamine sulfate (Glucomed) is a dual-modulatory mechanism that targets the metabolic and catabolic processes within joint tissue. This mechanism operates by influencing cellular anabolism and catabolism, which are distinct from pathways mediated by nerve-signal blockade.


Cartilage Anabolic Stimulation

Glucosamine sulfate targets chondrocytes by acting as a substrate precursor within the Hexosamine Biosynthesis Pathway (HBP). This action increases the concentration of available precursor, stimulating the biosynthesis of proteoglycans and Type II Collagen. This process directly affects the material properties of the cartilage matrix by enhancing the structural components.


Suppression of Catabolic Signaling

The drug functions as a suppressor of the pro-inflammatory transcription factor Nuclear Factor kappa B ( NF-kappa B) within joint cells. This interference reduces the gene expression of catabolic enzymes, specifically Matrix Metalloproteinases ( MMPs), and pro-inflammatory cytokines. The functional consequence is a suppression of enzymatic degradation within the joint tissue.


Physiological Modulation

These two mechanistic domains modulate joint tissue homeostasis. The confluence of driving anabolic processes and suppressing catabolic signaling results in a sustained modulation of the anabolic-catabolic balance within the joint structures.

Dosage and Administration Information

How to Use Glucomed: Administration Instructions

The use of Glucomed is defined by its specific dosage, route of administration, and timing. It is available for oral administration and is typically provided in forms such as tablets, capsules, or powder for oral solution.

Dosing and Frequency

Formulation Typical Adult Dose Typical Adult Frequency
Oral Preparations 1,500 mg Once daily or divided into three doses

The total daily dose of 1,500 mg is the standard amount for the symptomatic treatment of osteoarthritis. This may be taken as a single dose or divided into smaller doses throughout the day.

Administration Requirements

Doses of Glucomed may be taken with or without food, though taking the medication with meals may be preferred by some patients. For the powder formulation, the contents of the sachet should be dissolved in a glass of water before ingestion.

When using tablets or capsules, they should be swallowed with a sufficient amount of liquid. The consistency of use is important for the management of symptoms, as the effects are typically observed after a period of continuous treatment.

Population Rules

Glucomed is intended for use in the adult population. Its use is not recommended in children or adolescents due to a lack of data on safety and efficacy in these groups. Patients with significant renal or hepatic impairment should have their treatment monitored, as the pharmacological properties of the compound require appropriate consideration in these clinical contexts.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Glucomed (Glucosamine Sulfate)

Evidence for Use in Mild to Moderate Knee Osteoarthritis

Glucosamine sulfate was studied for its application in research exploring how symptoms change over time related to mild to moderate knee osteoarthritis. The core evidence was evaluated in numerous large-scale Randomized Controlled Trials (RCTs), a foundational study type, alongside comprehensive systematic reviews that look at the findings of multiple trials. In these studies, researchers monitored several key outcomes related to physical discomfort, including pain intensity and stiffness, and also examined outcomes reflecting daily functioning or activity level. Long-term studies monitored structural changes, such as the rate of Joint Space Narrowing (JSN).

Studies monitored how symptoms evolved in the observed populations, and findings describe patterns observed in the trials. Data show patterns related to changes in the radiological sign of disease progression (JSN) in specific long-term trials. However, some evidence suggests that the findings were mixed related to short-term pain relief, and there can be notable differences in the results across studies.

Long-Term Evidence and Effects on Disease Progression

The research exploring long-term data mainly focuses on extended periods beyond one year. This research examined the evaluation of changes in the progression of the condition, focusing on those structural outcomes of Joint Space Narrowing. Research examined a specific crystalline Glucosamine sulfate formulation over several years; studies monitored changes in measurements of joint space width and reported outcomes compared to placebo. Long-term effects are not fully established regarding physical function, and observational studies examined the need for major clinical events.

Limitations and Research Gaps

The body of evidence contributes to understanding symptom patterns, but several key limitations have been noted. The most notable findings was observed in some studies associated with only a specific, crystalline formulation of Glucosamine sulfate. Evidence quality varies across studies regarding symptomatic outcomes, and data for certain groups remain insufficient outside of the primary adult knee OA population. Additionally, comparative evidence is lacking for patients with specific comorbid conditions.

Frequently Asked Questions (FAQ)

Common questions about Glucomed (FAQ)


Q: What should a patient expect regarding symptom relief after starting this medicine?

Official documentation indicates that Glucomed is a slow-acting medicine, and relief of symptoms should not be expected immediately. Symptom improvement, particularly for pain, may not be experienced until after several weeks of treatment and possibly longer. This delayed onset is consistent with the drug class characteristics.


Q: Is it normal to not feel any improvement during the first few weeks of taking Glucomed?

Official documentation describes the relief of symptoms as a gradual process. Symptom relief may not be experienced until after several weeks, or sometimes even longer, due to the way the medicine influences the joint tissue. Lack of early improvement is therefore consistent with the known action of the medicine.


Q: Does having impaired kidney or liver function affect eligibility for Glucomed?

No specific dose recommendations can be given for Glucomed in patients with impaired kidney or liver function because formal studies have not been performed in these populations. If a patient has severe kidney or liver issues, administration requires medical supervision.


Q: Can the Glucomed tablet be broken in half to make it easier to swallow?

The tablet includes a score line, which is present only to facilitate breaking for ease of swallowing the tablet whole. This line is specifically not intended to divide the dose into two equal halves.


Q: Does Glucomed need to be taken with or without food for best results?

According to the official product information, the tablets can be taken either with or without food. Taking the medicine does not depend on mealtimes for proper effectiveness.


Q: Do regulatory documents mention the use of Glucomed for acute, sudden joint pain?

Official product information states that Glucomed is not indicated for the treatment of acute painful symptoms. This medicine is designed for the long-term, symptomatic relief of a chronic condition.


Q: Does Glucomed's efficacy differ depending on the severity of the osteoarthritis?

The medicine is specifically indicated in official documentation for the relief of symptoms in mild to moderate osteoarthritis of the knee. This indication is based on the evidence reviewed by regulatory authorities.


Q: Is Glucomed the same ingredient as the glucosamine supplements sold over-the-counter?

Glucomed is a specific formulation of crystalline glucosamine sulfate that is classified as a medicinal product in some countries. While other forms of glucosamine are sold as dietary supplements, this particular product is authorized and regulated as a medicine.


Q: How long does it usually take to notice a difference after starting Glucomed?

Studies and official information indicate that symptom relief may not be experienced until after several weeks of treatment. This delayed onset is consistent with the known characteristics of the medicine.


Q: If no relief is felt, how long should a person wait before discontinuing Glucomed treatment?

If a patient does not experience relief of symptoms after 2 to 3 months of continuous use, the official product information suggests that the continued treatment with glucosamine requires re-evaluation.


Q: What is the duration of an expected course of treatment with Glucomed?

The medicine is typically used for long-term symptom management. However, official regulatory documents state that the safety of continuous treatment beyond 3 years has not been established in research, and therefore treatment beyond this period cannot be formally recommended.


Q: Is monitoring of blood lipid (cholesterol) levels recommended while taking Glucomed?

Official documentation details that monitoring of blood lipid levels is recommended for patients who have known risk factors for cardiovascular disease.


Q: Is an increase in cholesterol levels a recognized, though uncommon, effect of Glucomed?

Regulatory documents note that hypercholesterolemia (elevated cholesterol) has been observed in a few cases in patients who were treated with glucosamine. This is a known, though not common, observation documented in official safety information.


Q: What should be watched for regarding potential effects on the heart or cardiovascular system?

Official warnings detail the recommendation for monitoring of blood lipid and blood pressure levels in patients with cardiovascular risk factors. Additionally, INR fluctuation has been reported in patients taking certain blood-thinning medications concurrently.


Q: Can Glucomed be taken at the same time as other common pain medicines, such as NSAIDs?

While formal interaction studies have not been performed for these combinations, official information indicates that analgesics (pain relievers) and NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) are considered for concomitant use, especially during the initial treatment period.


Q: Do food or dietary supplements affect how Glucomed works in the body?

Regulatory documents indicate that the medicine has known interactions with certain medicines and supplements. For example, there is a recognized interaction risk with oral vitamin K antagonists (blood thinners) and with antibiotics of the tetracycline class.


Q: Are there any specific warnings for use in elderly patients?

Official product information states that no specific dosage adjustment is detailed for otherwise healthy elderly patients based on clinical experience.


Q: Is Glucomed a prescription-only medicine, or can it be bought without a prescription?

The classification of this product varies by country. It is a specific medicinal product that is sold under prescription in certain countries, while other forms of glucosamine are generally available as supplements.


Q: Are there reports of drowsiness or dizziness associated with taking Glucomed?

Sleepiness has been reported as an adverse effect. Official warnings state that due to the potential for sleepiness or drowsiness to impair ability, the effect must be assessed before driving or operating machinery.


Q: What is the difference between the 'score line' on the tablet and dividing a dose?

The score line is a physical feature on the tablet that is only intended to facilitate breaking for easier swallowing. According to official instructions, it is not intended to divide the tablet into two equal parts for precise dosage adjustment.

How should Glucomed be stored and disposed of?

The official storage and disposal requirements for Glucomed (glucosamine hydrochloride) are strictly defined in regulatory labeling to maintain product quality and ensure safety.

Official Storage Conditions

Requirement Constraint Defined in Labeling
Temperature Limit Do not store above 30 C.
Environmental Protection Store in the original package to protect from moisture.
Child Safety Keep out of the reach and sight of children.

Waste Management

Official regulatory documents require that the disposal of unused medicinal product or waste material must be conducted in accordance with local requirements. There are typically no special requirements specified for its disposal beyond this standard instruction. These mandatory conditions define how the product must be stored and handled, ensuring its integrity until the expiry date.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Glucomed found in:

A-Z Index: